Cisatracurium-induced neuromuscular blockade in anticonvulsant treated neurosurgical patients

Journal of Neurosurgical Anesthesiology

Volumn 12, Issue 4, 2000, Pages 314-318

  Koenig, Heidi M ^a   Edwards, Terry L ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptics; Benzylisoquinolinium; Cisatracurium; Neuromuscular relaxant

Indexed keywords

CARBAMAZEPINE; CEFTIZOXIME; CISATRACURIUM; FENTANYL; FUROSEMIDE; ISOFLURANE; MANNITOL; MIDAZOLAM; PHENYTOIN; THIOPENTAL; VANCOMYCIN;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ELECTROMYOGRAM; FEMALE; HAND MUSCLE; HUMAN; MALE; NEUROMUSCULAR BLOCKING; NEUROSURGERY; PARALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; ANTICONVULSANTS; ATRACURIUM; DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED; MYOGRAPHY; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NEUROSURGICAL PROCEDURES;

EID: 0033809165     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200010000-00003     Document Type: Article

References (24)

1. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients
2. Effect of plasma anticonvulsant level on pipecuronium-induced neuromuscular blockade: Preliminary results
3. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium
4. Resistance to pancuronium in patients receiving carbamazepine
5. Drugs effective in the therapy of the epilepsies
6. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants
7. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opiod/barbiturate anesthesia
8. Importance of the organ-independent elimination of cisatracurium
9. Clinical use of the Relaxograph NMT-100
10. Improving the design of muscle relaxant studies-stabilization period and tetanic recruitment
11. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents
12. The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade
13. Presynaptic and postsynaptic depressant effects of phenytoin sodium at the neuromuscular junction
14. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission
15. Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin
16. Interaction of rocuronium (ORG9426) and phenytoin in a patient undergoing cadaver renal transplantation: A possible pharmacokinetic mechanism?
17. Accelerated recovery from pipecuronium in patients treated with chronic anticonvulsant therapy
18. Phenytoin-induced resistance to vecuronium
19. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes
20. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine
21. Recovery from mivacurium-induced neuromuscular blockade is not affected by anticonvulsant therapy
22. Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine
23. Influence of chronic anticonvulsant therapy with carbamazepine on mivacurium-induced neuromuscular blockade